These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1202 related items for PubMed ID: 7715343
1. Long-term efficacy of continuing hepatitis B vaccination in infancy in two Gambian villages. Whittle HC, Maine N, Pilkington J, Mendy M, Fortuin M, Bunn J, Allison L, Howard C, Hall A. Lancet; 1995 Apr 29; 345(8957):1089-92. PubMed ID: 7715343 [Abstract] [Full Text] [Related]
2. Efficacy of hepatitis B vaccine in the Gambian expanded programme on immunisation. Fortuin M, Chotard J, Jack AD, Maine NP, Mendy M, Hall AJ, Inskip HM, George MO, Whittle HC. Lancet; 1993 May 01; 341(8853):1129-31. PubMed ID: 8097813 [Abstract] [Full Text] [Related]
3. Vaccination against hepatitis B and protection against chronic viral carriage in The Gambia. Whittle HC, Inskip H, Hall AJ, Mendy M, Downes R, Hoare S. Lancet; 1991 Mar 30; 337(8744):747-50. PubMed ID: 1672389 [Abstract] [Full Text] [Related]
4. Long-term vaccination decreasing HBV in the Gambia. Vaccine Wkly; 1995 May 22; ():8-9. PubMed ID: 12346215 [Abstract] [Full Text] [Related]
5. Efficacy and effectiveness of infant vaccination against chronic hepatitis B in the Gambia Hepatitis Intervention Study (1986-90) and in the nationwide immunisation program. Peto TJ, Mendy ME, Lowe Y, Webb EL, Whittle HC, Hall AJ. BMC Infect Dis; 2014 Jan 07; 14():7. PubMed ID: 24397793 [Abstract] [Full Text] [Related]
6. The first five years of universal hepatitis B vaccination in South Africa: evidence for elimination of HBsAg carriage in under 5-year-olds. Tsebe KV, Burnett RJ, Hlungwani NP, Sibara MM, Venter PA, Mphahlele MJ. Vaccine; 2001 Jul 16; 19(28-29):3919-26. PubMed ID: 11427266 [Abstract] [Full Text] [Related]
7. Continuing risk for hepatitis B virus transmission among Southeast Asian infants in Louisiana. Mahoney FJ, Lawrence M, Scott C, Le Q, Lambert S, Farley TA. Pediatrics; 1995 Dec 16; 96(6):1113-6. PubMed ID: 7491231 [Abstract] [Full Text] [Related]
8. Response to hepatitis B vaccine in relation to the hepatitis B status of family members. Inskip HM, Hall AJ, Temple IK, Loik F, Herbage E, Chotard J, Whittle H. Int J Epidemiol; 1991 Sep 16; 20(3):770-3. PubMed ID: 1835453 [Abstract] [Full Text] [Related]
9. Hepatitis B vaccination in children: the Taiwan experience. Ni YH, Chen DS. Pathol Biol (Paris); 2010 Aug 16; 58(4):296-300. PubMed ID: 20116181 [Abstract] [Full Text] [Related]
10. Hepatitis B vaccination in infancy in The Gambia: protection against carriage at 9 years of age. Viviani S, Jack A, Hall AJ, Maine N, Mendy M, Montesano R, Whittle HC. Vaccine; 1999 Aug 06; 17(23-24):2946-50. PubMed ID: 10462228 [Abstract] [Full Text] [Related]
11. Hepatitis B vaccine in the Gambian Expanded Programme on Immunization: factors influencing antibody response. Inskip HM, Hall AJ, Chotard J, Loik F, Whittle H. Int J Epidemiol; 1991 Sep 06; 20(3):764-9. PubMed ID: 1835452 [Abstract] [Full Text] [Related]
12. [Preliminary analysis on the prevalence and causes of breakthrough hepatitis B virus infection among children in Shandong province, China]. Zhang L, Yan BY, Li MS, Song LZ, Lü JJ, Xu Q, Xu AQ. Zhonghua Yu Fang Yi Xue Za Zhi; 2013 Oct 06; 47(10):933-9. PubMed ID: 24378135 [Abstract] [Full Text] [Related]
13. Serological and molecular epidemiological outcomes after two decades of universal infant hepatitis B virus (HBV) vaccination in Nunavut, Canada. Huynh C, Minuk GY, Uhanova J, Baikie M, Wong T, Osiowy C. Vaccine; 2017 Aug 16; 35(35 Pt B):4515-4522. PubMed ID: 28736196 [Abstract] [Full Text] [Related]
14. The need for more aggressive follow-up of children born to hepatitis B surface antigen-positive mothers: lessons from the Louisiana Perinatal Hepatitis B Immunization Program. Kohn MA, Farley TA, Scott C. Pediatr Infect Dis J; 1996 Jun 16; 15(6):535-40. PubMed ID: 8783352 [Abstract] [Full Text] [Related]
15. An efficacy trial of a mammalian cell-derived recombinant DNA hepatitis B vaccine in infants born to mothers positive for HBsAg, in Shanghai, China. Halliday ML, Kang LY, Rankin JG, Coates RA, Corey PN, Hu ZH, Zhou TK, Yuan GJ, Yao FL. Int J Epidemiol; 1992 Jun 16; 21(3):564-73. PubMed ID: 1386063 [Abstract] [Full Text] [Related]
16. Persistence of protection to hepatitis B vaccine and response to booster dose among children and adolescents in Dakahleya- Egypt. Salama II, Sami SM, Salama SI, Foud WA, Abdel Hamid AT, Said ZN. Egypt J Immunol; 2014 Jun 16; 21(1):13-26. PubMed ID: 25204041 [Abstract] [Full Text] [Related]
17. Long-term protection against carriage of hepatitis B virus after infant vaccination. van der Sande MA, Waight P, Mendy M, Rayco-Solon P, Hutt P, Fulford T, Doherty C, McConkey SJ, Jeffries D, Hall AJ, Whittle HC. J Infect Dis; 2006 Jun 01; 193(11):1528-35. PubMed ID: 16652281 [Abstract] [Full Text] [Related]
18. Prevalence of HBsAg carriers in native and immigrant pregnant female populations in Israel and passive/active vaccination against HBV of newborns at risk. Bogomolski-Yahalom V, Granot E, Linder N, Adler R, Korman S, Manny N, Tur-Kaspa R, Shouval D. J Med Virol; 1991 Aug 01; 34(4):217-22. PubMed ID: 1834799 [Abstract] [Full Text] [Related]
19. Hepatitis B virus infection in two Gambian villages. Whittle HC, Bradley AK, McLauchlan K, Ajdukiewicz AB, Howard CR, Zuckerman AJ, McGregor IA. Lancet; 1983 May 28; 1(8335):1203-6. PubMed ID: 6133999 [Abstract] [Full Text] [Related]
20. [Long-term efficacy and persistence of Chinese infants after receiving only active plasma-derived hepatitis B vaccine]. Xia G, Jia Z, Yan T, Li R, Liu H, Xu Z, Cao H, Liu C. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2002 Jun 28; 16(2):146-9. PubMed ID: 12196826 [Abstract] [Full Text] [Related] Page: [Next] [New Search]